- Nachrichtendetail
-
18.04.2024 14:38:37 - dpa-AFX: *ABBVIE'S PHASE 3 STUDY OF UPADACITINIB SHOWS POSITIVE RESULTS IN GIANT CELL ARTERITIS PATIENTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Xetra | 157,980 | 19.06.24 16:31:15 | -2,640 | -1,64% | 157,820 | 160,880 | 160,340 | 160,620 |
